Wegener's disease and exposure to silica: Study of the physiopathological mechanisms;Maladie de Wegener après exposition à la silice: Étude des mécanismes physiopathologiques

Presse Medicale

Volumn 33, Issue 19 I, 2004, Pages 1349-1351

  Moulin, Philippe ^b   Lehucher Michel, Marie Pascale ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYELOBLASTIN; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE;

AUTOIMMUNE DISEASE; BIOSYNTHESIS; CLINICAL FEATURE; EXOCYTOSIS; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; GRANULOMATOUS VASCULITIS; HUMAN; NEUTROPHIL; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PATHOPHYSIOLOGY; PNEUMOCONIOSIS; POLYARTERITIS NODOSA; REVIEW; RISK FACTOR; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS;

EID: 9144220178     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98922-1     Document Type: Review

References (22)

1. Dewitte JD, Choucroun P, Leroyer C. Pathologies dues à l'inhalation de poussières de silice. Toxicologie Pathologie Professionnelle. Encycl Méd Chir Elsevier, Paris 1999; 16-002-A-24.
2. Bachmeyer C, Grateau G, Gomez V et al. Périartérite noueuse chez un prothésiste dentaire. Presse Med 1994; 23: 446.
3. Lehucher-Michel MP, Raulot-Lapointe H, Kacel M, Conejerot P. Une sclérodermie systémique progressive associée à une exposítion au talc. Arch Mal Prof 2000; 61: 194-200.
4. Ozoran K, Ucan H, Tudkak H, Canel N, Yucel M. Systemic lupus erythematosus ansing in a patient with chronic silicosis. Rheumatol Int 1997; 16: 217-18.
5. Parks CG, Karsten C, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspert 1999; 107: 793-801.
6. Puisieux F, Hachulla E, Brouillard M, Natron PY, Devulder B. Silicose et syndrome de Goujerot-Sjögren primitif. Rev Med Interne 1994; 15: 575-9.
7. Moulin P, Lehucher-Michel MP. Granulomatose de Wegener et exposition à la silice cristalline. Arch Mal Prof. In press.
8. Cotch MF, Hoffman GS, Yerg DE, Kaufman GJ, Targonsky P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Arthritis Rheum 1996; 39: 87-92.
9. Colby TV, Specks U. Wegener's granulomatosis in the 1990s - A pulmonary pathologist's perspective. Churg A, Katzenstein A eds. The lung: current concepts, Philadelphia, Williams and Wilkins 1993; 195-218.
10. Fauci AS. Vascularites. Harrison's principes of internal medecine. 14th ed. In: Faici A, Braunwald E, Isselbacher KJ et al. eds. Mc Graw-Hill, London 2000; 2199-213.
11. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechet JM. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases, Chert 1990; 97: 906-12.
12. Caplan A. Certain unusual radiologic appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953; 8: 29-34.
13. Erasmus LD. Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Labor Clin Med 1957; 3: 209-31.
14. Nuyts GD, Van Vlem E, De Vos A et al. Wegener granulomatosis is associated to exposure to silicon compounds: a case control study. Nephrol Dial Transplant 1995; 10: 1162-5.
15. Stratta P, Messueroti A, Canavese C et al. The role of metals in autoimmune vasculitis: epidemiological and pathogenic study. Sci Total Environ 2001; 270: 179-90.
16. Büchler M, Longuet C, Degenne D et al. Maladie de Wegener et exposition professionnelle. Journées annuelles - TOUR 2000, II Réunion commune Société francophone de dialyse, société de Néphrologie, vendredi 23 juin 2000.
17. Suskovic T, Mose L, Vucicevic Z. Pulmonary silicosis complicated by systemic vaculitis. Plucne Bolesti 1990; 42: 77-9.
18. Meyer U. Wegener's granulomatosis associated with silicosis. Dial transplant 1994; 9: 559-61.
19. Castranova V, Vallyathan V. Silicosis and coal worker's pneumoconiosis. Environ Health Perspect 2000; 108, Supp 4.
20. Castranova V, Dalal NS, Vallyatan V. Role of surface free radicals in the pathogenicity of silica. In: Castranova V, Vallyathan V, Wallace WE eds, Silica and silica-induced diseases. CRS Press, Boca Raton 1996; 91-105.
21. Savage CO, Pottinger BE, Cohen Tervaert JW et al. Autoantibodies developing to myeloperoxydase and proteinase 3 in systemic vascilitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992; 141: 335-42.
22. Mayet WJ, Csenok E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82: 1221-9.